GIORDANO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 55.705
EU - Europa 39.907
AS - Asia 23.335
SA - Sud America 5.513
AF - Africa 1.776
Continente sconosciuto - Info sul continente non disponibili 1.277
OC - Oceania 97
Totale 127.610
Nazione #
US - Stati Uniti d'America 54.939
GB - Regno Unito 11.596
CN - Cina 7.762
SG - Singapore 6.883
IT - Italia 5.809
RU - Federazione Russa 5.731
IE - Irlanda 4.934
BR - Brasile 4.603
UA - Ucraina 3.307
FR - Francia 2.628
VN - Vietnam 2.576
HK - Hong Kong 2.261
DE - Germania 2.096
SE - Svezia 1.813
KR - Corea 1.213
FI - Finlandia 983
ZA - Sudafrica 966
IN - India 709
BD - Bangladesh 450
NG - Nigeria 407
CA - Canada 341
AR - Argentina 324
IQ - Iraq 228
TR - Turchia 221
MX - Messico 190
NL - Olanda 173
EC - Ecuador 166
ID - Indonesia 155
ES - Italia 137
JP - Giappone 127
PK - Pakistan 103
AT - Austria 98
PL - Polonia 95
BE - Belgio 94
CO - Colombia 94
SA - Arabia Saudita 90
CL - Cile 89
VE - Venezuela 83
AU - Australia 77
UZ - Uzbekistan 75
KE - Kenya 69
MA - Marocco 64
PY - Paraguay 61
EE - Estonia 52
CI - Costa d'Avorio 51
NP - Nepal 51
EG - Egitto 50
PH - Filippine 44
TN - Tunisia 44
AE - Emirati Arabi Uniti 43
JO - Giordania 43
MY - Malesia 42
PE - Perù 40
AZ - Azerbaigian 39
JM - Giamaica 37
EU - Europa 36
CZ - Repubblica Ceca 32
DZ - Algeria 32
IL - Israele 32
GR - Grecia 31
TT - Trinidad e Tobago 31
UY - Uruguay 31
IM - Isola di Man 29
LT - Lituania 29
AL - Albania 28
HN - Honduras 28
RO - Romania 28
HU - Ungheria 27
CH - Svizzera 26
CR - Costa Rica 26
OM - Oman 25
ET - Etiopia 23
KZ - Kazakistan 21
SN - Senegal 20
BO - Bolivia 19
GT - Guatemala 19
IR - Iran 18
LB - Libano 17
NZ - Nuova Zelanda 17
PT - Portogallo 17
BY - Bielorussia 15
DO - Repubblica Dominicana 15
KG - Kirghizistan 15
PA - Panama 15
BG - Bulgaria 14
CY - Cipro 13
HR - Croazia 13
NI - Nicaragua 13
RS - Serbia 12
SC - Seychelles 12
SV - El Salvador 12
BB - Barbados 11
DK - Danimarca 11
LV - Lettonia 11
KW - Kuwait 10
MD - Moldavia 9
TW - Taiwan 9
BA - Bosnia-Erzegovina 8
PS - Palestinian Territory 8
TH - Thailandia 8
Totale 126.232
Città #
Southend 10.597
Fairfield 6.202
Dallas 5.943
Dublin 4.884
Ashburn 3.891
Singapore 3.635
Woodbridge 2.904
Chandler 2.772
Jacksonville 2.711
Houston 2.454
Wilmington 2.428
Seattle 2.322
Hong Kong 2.148
Milan 2.053
Cambridge 2.048
Menlo Park 2.027
Council Bluffs 1.637
Beijing 1.536
Moscow 1.495
Hefei 1.470
San Jose 1.423
Ann Arbor 1.344
Princeton 1.332
Seoul 1.202
Santa Clara 1.046
The Dalles 987
Nanjing 936
Johannesburg 876
Ho Chi Minh City 836
Rome 810
Lauterbourg 696
Siena 661
Los Angeles 612
Hanoi 564
San Mateo 513
Boardman 446
Abuja 405
New York 369
São Paulo 368
San Diego 364
Helsinki 353
Nanchang 353
Buffalo 321
Columbus 312
Shenyang 224
Düsseldorf 215
Tianjin 190
Dong Ket 175
London 175
Chicago 170
Figino 165
Redondo Beach 163
Hebei 161
Changsha 157
Bengaluru 154
Rio de Janeiro 154
Kunming 151
Delhi 148
San Francisco 143
Florence 140
Shanghai 139
Munich 137
Turin 135
Frankfurt am Main 132
Jiaxing 120
Norwalk 117
Orem 114
Toronto 113
Naples 108
Belo Horizonte 105
Nuremberg 104
Haiphong 103
Tokyo 102
Da Nang 99
Baghdad 94
Brussels 91
Dearborn 91
Izmir 84
Falls Church 79
Atlanta 78
Brasília 78
Hangzhou 78
Porto Alegre 77
Venezia 76
Chennai 74
Brooklyn 72
Curitiba 72
Lappeenranta 72
Amsterdam 71
Philadelphia 71
Dhaka 70
Montreal 70
Guangzhou 67
Jinan 67
Zhengzhou 67
Tashkent 65
Warsaw 63
Vienna 59
Washington 58
Biên Hòa 54
Totale 88.497
Nome #
A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma 478
Incidence of breast cancer in Italy: mastectomies and quadrantectomies performed between 2000 and 2005. 459
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 409
Possible repurposing of pyrvinium pamoate for the treatment of mesothelioma: A pre-clinical assessment 365
"A method of inhibiting cancer cell growth using a vector expressing pRb2/p130." 358
4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors 349
A case of human polyomavirus Bk infection in a patient affected by late stage prostate cancer: could viral infection be correlated with cancer progression? 339
" Methods of inhibiting smooth muscle cell proliferation and preventing restenosis with a vector expressing RB2/p130 " 337
PPARα Antagonist AA452 Triggers Metabolic Reprogramming and Increases Sensitivity to Radiation Therapy in Human Glioblastoma Primary Cells 334
Aromatase and 5-alpha reductase gene expression: modulation by pain and morphine treatment in male rats 334
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives 332
2,3,7,8-Tetrachlorodibenzo-p-dioxin modifies expression and nuclear/cytosolic localization of bovine herpesvirus 1 immediate-early protein (bICP0) during infection 332
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 331
Depletion of the RNA binding protein HNRNPD impairs homologous recombination by inhibiting DNA-end resection and inducing R-loop accumulation 325
"Peptide inhibitors of cyclin-dependent kinase activity and uses thereof." 324
"pRb2/p130 Peptide Inhibitors of cdk2 Kinase activity" 318
12-O-tetradecanoylphorbol-13-acetate and EZH2 inhibition: A novel approach for promoting myogenic differentiation in embryonal rhabdomyosarcoma cells 318
Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors. 313
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 306
The HNRNPD protein from DNA repair to immune response 305
A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells 304
CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy 301
2,3,7,8-Tetrachlorodibenzo-p-dioxin increases bovine herpesvirus type-1 (BHV-1) replication in Madin-Darby Bovine Kidney (MDBK) cells in vitro 298
The zebrafish as a model for nociception studies. 298
"Methods for determining presence of cancer by analyzing the expression of cyclin-dependent kinase 9 (CDK9) and /or cyclin T1 in lymphoid tissue." 297
"Gene modulation by Rb2/p130 expression." 295
NONO ubiquitination is mediated by FBW7 and GSK3 β via a degron lost upon chromosomal rearrangement in cancer 295
"Methods of diagnosis, prognosis and treating breast cancer." 292
"Genetic and epigenetic alterations in the diagnosis and treatment of cancer." 288
Virtual Reality in Health System: Beyond Entertainment. A Mini-Review on the Efficacy of VR During Cancer Treatment 285
"Peptide inhibitors of cyclin-dependent kinase activity and uses thereof." 284
Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma 282
A functional biological network centered on XRCC3: A new possible marker of chemoradiotherapy resistance in rectal cancer patients 278
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach 277
"Regenerating and enhancing development of muscle tissue." 277
"Methods for the diagnosis and prognosis of cancer." 276
Antitumoral potential, antioxidant activity and carotenoid content of two Southern Italy tomato cultivars extracts: San Marzano and Corbarino 276
CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation 275
Extracellular Matrix and Colorectal Cancer: How Surrounding Microenvironment Affects Cancer Cell Behavior? 275
Zebrafish Tmem230a cooperates with the Delta/Notch signaling pathway to modulate endothelial cell number in angiogenic vessels 275
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 273
"Determination of Cyclin-Dependent Kinase Inhibitor p27 levels as a prognostic factor in cancer patients." 271
New players in ovarian cancer. 268
Cdk9/Cyclin T1 complex: a key player during the activation/differentiation process of normal lymphoid B cells 265
Gene and MicroRNA Expression Are Predictive of Tumor Response in Rectal Adenocarcinoma Patients Treated With Preoperative Chemoradiotherapy 264
Study of viral integration of HPV-16 in young patients with LSIL 263
Cdk9 regulates neural differentiation and its expression correlates with the differentiation grade of neuroblastoma and PNET tumors 263
Dissecting Pin1 and phospho-pRb regulation 263
Differential expression of Rb2/p130 and p107 in normal human tissues and in primary lung cancer 262
Uric Acid Amplifies Aβ Amyloid Effects Involved in the Cognitive Dysfunction/Dementia: Evidences From an Experimental Model In Vitro 262
A study of quiet eye's phenomenon in the shooting section of "laser run" of modern pentathlon 262
Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New Drugs 259
An Intrinsically Disordered Region of the Acetyltransferase p300 with Similarity to Prion-Like Domains Plays a Role in Aggregation 258
Anticancer therapeutic strategies based on CDK inhibitors 255
Effect of rMnSOD on Sodium Reabsorption in Renal Proximal Tubule in Ochratoxin A—Treated Rats 255
RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy 252
From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells 251
Triple negative breast cancer: Looking for the missing link between biology and treatments 250
NSP 5a3a's link to nuclear-cyto proteins B23 and hnRNP-L between normal and aberrant breast cell lines 249
Ubiquitin-mediated protein degradation and methylation-induced gene silencing cooperate in the inactivation of the INK4/ARF locus in Burkitt`s lymphoma cell lines 249
CDK9 (PITALRE): a multifunctional cdc2-related kinase 249
Wasting lives: the effects of toxic waste exposure on health. The case of Campania, Southern Italy 248
NONO regulates the intra-S-phase checkpoint in response to UV radiation 248
Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancer 248
The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression 246
Cdk9-55: a new player in muscle regeneration 246
Burkitt’s lymphoma: new insights into molecular pathogenesis 246
The effects of HIV 1 Tat Protein on cell cycle during cervical carcinogenesis 243
Multifaceted Breast Cancer: The Molecular Connection With Obesity 240
PRMT5 silencing selectively affects MTAP-deleted mesothelioma: In vitro evidence of a novel promising approach 240
Gastroprotective effects of L-Lysine salification of ketoprofen in ethanol-injured gastric mucosa 239
Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition 238
Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin 238
Dysregulated calcium homeostasis and oxidative stress in chronic myeloid leukemia (CML) cells 238
The Prolyl Isomerase Pin1 Acts Synergistically with CDK2 to Regulate the Basal Activity of Estrogen Receptor α in Breast Cancer 237
”Tumor Suppressor Protein pRB2, related gene products, and DNA encoding therefor” 236
SRC family kinase inhibition through a new pyrazolo[3,4-d]pyrimidine derivative as a feasible approach for glioblastoma treatment 236
Comparison of Dasatinib, Nilotinib, and Imatinib in the Treatment of Chronic Myeloid Leukemia 235
Alterations of the Plasma Peptidome Profiling in Colorectal Cancer Progression 234
Clinical Predictive Circulating Peptides in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy 234
Effects of antioxidants on apoptosis induced by dasatinib and nilotinib in K562 cells 234
CDK inhibitors: from the bench to clinical trials 233
Roles of PPAR transcription factors in the energetic metabolic switch occurring during adult neurogenesis 232
Overexpression and Nucleolar Localization of γ-Tubulin Small Complex Proteins GCP2 and GCP3 in Glioblastoma 232
Translational Research and Plasma Proteomic in Cancer 232
Vacuolated PAS-positive lymphocytes as an hallmark of Pompe disease and other myopathies related to impaired autophagy 231
Activation of MyoD-dependent transcription by cdk9/cyclin T2 230
Virtual Reality as a Distraction Intervention to Relieve Pain and Distress During Medical Procedures: A Comprehensive Literature Review 230
MicroRNA-34a and MicroRNA-181a Mediate Visfatin-Induced Apoptosis and Oxidative Stress via NF-κB Pathway in Human Osteoarthritic Chondrocytes 230
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer 229
Extreme N terminus of E1A oncoprotein specifically associates with a new set of cellular proteins 228
MicroRNA-125a-5p Is a Downstream Effector of Sorafenib in Its Antiproliferative Activity Toward Human Hepatocellular Carcinoma Cells 228
Cdk9, a member of the cdc2-like family of kinases, binds to gp130, the receptor of the IL-6 family of cytokines 228
The role of the Cdk9/Cyclin T1 complex in T cell differentiation 227
An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer 227
Pain and morphine change CNS aromatase and 5-alfa reductase gene expression in male rats 226
Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells 226
Expression of the ALK protein by anaplastic large-cell lymphomas correlates with high proliferative activity 226
Tumor Microenvironment Versus Cancer Stem Cells in Cholangiocarcinoma: Synergistic Effects? 225
Androgen receptor serine 81 mediates Pin1 interaction and activity 224
Totale 27.285
Categoria #
all - tutte 419.973
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 419.973


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228.324 0 1.043 692 480 523 363 596 343 603 1.014 729 1.938
2022/202310.732 815 445 1.200 1.732 1.138 2.639 121 863 1.035 143 398 203
2023/20245.718 329 164 464 145 196 1.659 2.114 111 33 110 37 356
2024/202514.867 367 886 806 784 933 781 179 939 1.198 1.199 1.847 4.948
2025/202639.334 3.192 6.416 4.537 4.193 5.086 1.420 4.629 1.683 1.251 1.829 987 4.111
2026/20273.349 1.871 1.478 0 0 0 0 0 0 0 0 0 0
Totale 127.610